Outcome measures for chronic inflammatory demyelinating polyneuropathy in research: relevance and applicability to clinical practice.

Rajabally, Yusuf A and Fatehi, Farzad (2019) Outcome measures for chronic inflammatory demyelinating polyneuropathy in research: relevance and applicability to clinical practice. Neurodegenerative disease management, 9 (5). pp. 259-266. ISSN 1758-2032.

Full text not available from this repository.
Official URL: https://www.futuremedicine.com/doi/abs/10.2217/nmt...

Abstract

Outcome measures are recommended in the management of chronic inflammatory demyelinating polyneuropathy (CIDP). Various scales have been proposed in recent years, some now commonly utilized in daily clinical practice. The available evidence base relies itself on randomized controlled trial data obtained over the past 30 years, with several studies using different primary and secondary outcomes. We here review the different outcome measures used in CIDP research in relation to those currently recommended for clinical management. We consider the evidence base for CIDP treatment from the primary and secondary outcomes used in these studies and attempt to assess how this may relate to current clinical practice of routine evaluation of treatment effects and long-term monitoring.

Item Type: Article
Subjects: WA Patients. Primary care. Medical profession. Forensic medicine
WL Nervous system. Neurology
Divisions: Emergency Services > Neurology
Related URLs:
Depositing User: Mrs Yolande Brookes
Date Deposited: 10 Oct 2019 12:59
Last Modified: 10 Oct 2019 12:59
URI: http://www.repository.uhblibrary.co.uk/id/eprint/2458

Actions (login required)

View Item View Item